Breast Cancer Briefing, hosted by Dr. Sara Nunnery, a breast medical oncologist and the director of Breast Cancer Research at ...

Dr. Sara Nunnery and Dr. Neil Iyengar discuss metabolic health, GLP-1s and prescribing exercise to improve outcomes for breast cancer survivors.

Transitioning from support recipient to supporter may restore agency and purpose, with brief outreach to newly diagnosed patients potentially delivering disproportionate calming and reframing benefits ...

Dry mouth and fibrosis remain among the most impactful long-term side effects for Stef Gayhart following treatment for oral ...

In this segment, Dr. Gregory Vidal discusses practical steps patients can take to manage side effects while undergoing ...

In this segment, Dr. Gregory Vidal explains why CDK4/6 inhibitors are commonly added to endocrine therapy in the treatment of ...

In this segment, Dr. Gregory Vidal discusses the role of estrogen receptor antagonists in the treatment of ER-positive, ...

In this segment, Dr. Gregory Vidal explains how hormone, or endocrine, therapies work to slow or stop cancer growth in ...

In this segment, Dr. Gregory Vidal explains what it means when endocrine therapy stops working in ER-positive, HER2-negative ...

In this segment, Dr. Gregory Vidal discusses how initial treatment options are selected for patients with ER-positive, ...

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to ...